Phenylacetyl chloride → 2-(4-(Morpholine-4-carbonyl)phenylamino)-6-(4-(2-phenylacetyl)piperazin-1-yl)nicotinamide

HRID 2044047노트

반응식

HRID 2044047 반응식
[N:1]1([C:7]([C:9]2[CH:14]=[CH:13][C:12]([NH:15][C:16]3[N:24]=[C:23]([N:25]4[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]4)[CH:22]=[CH:21][C:17]=3[C:18]([NH2:20])=[O:19])=[CH:11][CH:10]=2)=[O:8])[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.CCN(CC)CC.[C:38]1([CH2:44][C:45](Cl)=[O:46])[CH:43]=[CH:42][CH:41]=[CH:40][CH:39]=1>C1COCC1.C(Cl)Cl>[N:1]1([C:7]([C:9]2[CH:14]=[CH:13][C:12]([NH:15][C:16]3[N:24]=[C:23]([N:25]4[CH2:30][CH2:29][N:28]([C:45](=[O:46])[CH2:44][C:38]5[CH:43]=[CH:42][CH:41]=[CH:40][CH:39]=5)[CH2:27][CH2:26]4)[CH:22]=[CH:21][C:17]=3[C:18]([NH2:20])=[O:19])=[CH:11][CH:10]=2)=[O:8])[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1

참가 물질

6

반응물 3

HCID 7679Phenylacetyl chlorideHCID 8471TriethylamineHCID 498463872-(4-(Morpholine-4-carbonyl)phenylamino)-6-(piperazin-1-yl)nicotinamide

생성물 1

HCID 574896042-(4-(Morpholine-4-carbonyl)phenylamino)-6-(4-(2-phenylacetyl)piperazin-1-yl)nicotinamide수율 38.9%

시약·촉매·용매 2

HCID 6344Dichloromethane용매2회HCID 8028Tetrahydrofuran용매

실험 절차

To a suspension of 2-(4-(morpholine-4-carbonyl)phenylamino)-6-(piperazin-1-yl)nicotinamide (28 mg, 0.068 mmol) and Et3N (0.019 mL, 0.136 mmol) in THF (2 mL) and CH2Cl2 (2.000 mL) was added 2-phenylacetyl chloride (10.55 mg, 0.068 mmol). The reaction mixture was stirred at rt for 10 min, diluted with CH2Cl2, washed with satd NaHCO3, separated, and concentrated. The residue was purified by prep-HPLC. The product containing fractions were collected, basified with 1N NaOH, extracted with CH2Cl2, separated, and concentrated to give 14 mg of 2-(4-(morpholine-4-carbonyl)phenylamino)-6-(4-(2-phenylacetyl)piperazin-1-yl)nicotinamide as a white solid. LCMS: (M+H)+=529.40. 1H NMR (400 MHz, CDCl3) δ ppm 11.17 (1H, s), 7.63 (2H, d, J=8.56 Hz), 7.55 (1H, d, J=8.81 Hz), 7.35-7.40 (2H, m), 7.31-7.35 (2H, m), 7.23-7.31 (3H, m), 5.99 (1H, d, J=8.81 Hz), 5.59 (2H, s), 3.50-3.81 (18H, m).

후처리

  1. washwashed with satd NaHCO3
  2. customseparated
  3. concentrationconcentrated
  4. customThe residue was purified by prep-HPLC
  5. additionThe product containing fractions
  6. customwere collected
  7. extractionextracted with CH2Cl2
  8. customseparated
  9. concentrationconcentrated

출처 및 근거

ORD 기록
ord-210c26547d5145648cc0aee66acf8bd9
출처 데이터셋
uspto-grants-2013_11
특허 번호
US08586751B2

반응 노트

불러오는 중…